JPRN-UMIN000000474已完成2 期
Double-blind Placebo-controlled Clinical Trial of Leuprorelin acetate in Patients with Spinal and Bulbar Muscular Atrophy (SBMA) - Clinical Trial of Leuprorelin acetate in Patients with SBMA
Department of Neurology, Nagoya University School of Medicine0 个研究点目标入组 40 人开始时间: 2006年9月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 70years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) Patients with past medical history of allergy to leuprorelin acetate 2) Patients who have severe complications and are not appropriate to participate to the trial.. 3) Patients who have taken testosterone within 8 weeks prior to the informed consent.
研究者
相似试验
已完成
不适用
A double-blind placebo-controlled clinical trial of botulinum toxin type A injection therapy in patients with Japanese cedar pollinosisJapanese cedar pollinosisJPRN-UMIN000001657Department of Otorhinolaryngology, Head and Neck Surgery Faculty of Medicine, University of Yamanash32
已完成
不适用
A double-blind placebo-controlled clinical trial of botulinum toxin type A injection therapy in patients with Japanese cedar pollinosis 2010Japanese cedar pollinosisJPRN-UMIN000003065Department of Otorhinolaryngology, Head and Neck Surgery Faculty of Medicine, University of Yamanashi45
已完成
不适用
A double-blind placebo-controlled clinical trial of botulinum toxin type A injection therapy in patients with Japanese cedar pollinosis 2011Japanese cedar pollinosisJPRN-UMIN000004862Department of Otorhinolaryngoloty, Head and Neck Surgery Faculty of Medicine, University of Yamanashi36
Unknown
2 期
A Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Interferon Alfa-n3 Therapy in Addition to Standard of Care in Adults Hospitalized Due to Acute Severe InfluenzaCTRI/2010/091/001115Hemispherx Biopharma Inc60
招募中
3 期
Evaluation of the effect of Ivermectin in treatment of outpatients with COVID-19IRCT20111224008507N4Mazandaran University of Medical Sciences1,000